Your browser doesn't support javascript.
loading
Quality assurance of colonoscopy within the Dutch national colorectal cancer screening program.
Bronzwaer, Maxime E S; Depla, Annekatrien C T M; van Lelyveld, Niels; Spanier, Bernhard W M; Oosterhout, Yvonne H; van Leerdam, Monique E; Spaander, Manon C W; Dekker, Evelien.
Afiliação
  • Bronzwaer MES; Department of Gastroenterology and Hepatology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
  • Depla ACTM; Department of Gastroenterology and Hepatology, MC Slotervaart, Amsterdam, the Netherlands.
  • van Lelyveld N; Department of Gastroenterology and Hepatology, St. Antonius Hospital, Nieuwegein, the Netherlands.
  • Spanier BWM; Department of Gastroenterology and Hepatology, Rijnstate Hospital, Arnhem, the Netherlands.
  • Oosterhout YH; Dutch Screening Organizations, Amsterdam, the Netherlands.
  • van Leerdam ME; Department of Gastroenterology and Hepatology, NKI-AVL, Amsterdam, the Netherlands.
  • Spaander MCW; Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, the Netherlands.
  • Dekker E; Department of Gastroenterology and Hepatology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
Gastrointest Endosc ; 89(1): 1-13, 2019 01.
Article em En | MEDLINE | ID: mdl-30240879
ABSTRACT
Colorectal cancer (CRC) screening is capable of reducing CRC-related morbidity and mortality. Colonoscopy is the reference standard to detect CRC, also providing the opportunity to detect and resect its precursor lesions colorectal polyps. Therefore, colonoscopy is either used as a primary screening tool or as a subsequent procedure after a positive triage test in screening programs based on non-invasive stool testing or sigmoidoscopy. However, in both settings, colonoscopy is not fully protective for the occurrence of post-colonoscopy CRCs (PCCRCs). Because most PCCRCs are the result of colonoscopy-related factors, a high-quality procedure is of paramount importance to assure optimal effectiveness of CRC screening programs. For this reason, at the start of the Dutch fecal immunochemical test (FIT)-based screening program, quality criteria for endoscopists performing colonoscopies in FIT-positive screenees, as well as for endoscopy centers, were defined. In conjunction, an accreditation and auditing system was designed and implemented. In this report, we describe the quality assurance process for endoscopists participating in the Dutch national CRC screening program, including a detailed description of the evidence-based quality criteria. We believe that our experience might serve as an example for colonoscopy quality assurance programs in other CRC screening programs.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma / Neoplasias Colorretais / Adenoma / Colonoscopia / Detecção Precoce de Câncer Tipo de estudo: Diagnostic_studies / Screening_studies Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Gastrointest Endosc Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma / Neoplasias Colorretais / Adenoma / Colonoscopia / Detecção Precoce de Câncer Tipo de estudo: Diagnostic_studies / Screening_studies Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Gastrointest Endosc Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Holanda